简介:ThesorptionbehaviorofN-methyl-2-thio-imidazoleresin(MTIR)forRh(Ⅲ)wasinvestigated.TheoptmumsorptionconditionofMTIRforRh(Ⅲ),sorptionratet1/2=84min,sorptioncapacity1.37mmolRh(Ⅲ)/gMTIR,[140.5mgRh(Ⅲ)/gMTIR],sorptionmolarratio0.34Rh(Ⅲ)/functionalgroup,distributioncoefficientD=2.5×10^3mg·g^-1weredetermined.ThesorptionselectivityofMTIRforRh(Ⅲ)inthepresenceofcommonmetalions,Fe^3+,Co^2+,Ni^2+andCu^2+wasexamined.Rh(Ⅲ)adsorbedonMTIRcanbeelutedquantitativelybyusingamixedsolutioncomposedof20%thio-urea-acetone:6molHCl.dm^-3(1:1vol.)usedasaneluent.Rh(Ⅲ)canbeseparatedfromthemixtureofRh(Ⅲ)andFe^3+,Co^2+,Ni^2+,Cu^2+byusingD72resinandMTIRsuccessively.
简介:摘要目的通过检测Rh阴性血型及其抗体,为临床预防溶血性输血反应和新生儿溶血病的发生提供实验室依据。方法对6604例我院需要输血的患者通过抗D(IgM)血型定型试剂进行Rh(D)血型抗原检测,通过盐冰法、聚凝胺法、间接抗人球蛋白法检测Rh阴性血中的抗体。结果该组受检者中检出Rh(D)阴性37例,Rh(D)阴性率为0.48%(32/6604),其中检出Rh血型免疫性抗体2例。结论常规对Rh阴性血型进行筛查及其抗体的检测,能防止溶血性输血反应和新生儿溶血病的发生,对输血安全有重要意义。
简介:摘 要 阐述了ABO血型与Rh血型在分型,血型抗原的化学本质、产生方式、种类数量及分布,控制抗原合成的基因座位数量和位置,血型抗体种类,血型鉴定方法,血型不合所导致的溶血性输血反应和新生儿溶血病发生时机等方面的差异。
简介:DuetofastdevelopmentofChinesesteelindustry,continuousadjustmentofproduct,improvementofquality,researchofvalue-addedproduct,RHtechnologyissignificantlydeveloped.MoreandmoresteelplantsarecoveredwithRHfacilities.RHratioisgrowingrapidlyaswell.Overpastdecade,throughassimilatingadvancedforeigntechnologiesandfurtherrefiningthem,ChineselargescalesteelplantsmasterthetechnologyofRHproduction,operation,maintenanceandmakeitmorewidespread.RHfunctionsarewellappliedandimproved.RHismorewidelyeffectivelyputintouse.Throughindependentinnovation,RHcoredevicesandtechnology,suchasRHvacuumpump,oxygentoplance,vacuumvesselpreheatinglance,ladleliftingdeviceetc.haverealizedlocalization.Thedevelopmentofequipmentdesign,softwaredesign,equipmentmanufacturingtechnology,equipmentmounting,testtechnologyandEPCmanagementmakesequipmentconfigurationmoreflexible,equipmentmorefunctionalandstable,easiertooperateandmaintain.Italsoguaranteeshighlyeffectiveandlowenergyconsumptionproductionandqualityofsteel,reachesinternationaladvancedlevel,lowersthecostofRHconstructionandoperation,makesafter-sakeservicemoreconvenient.HowtocontinuouslyoptimizeanddevelopRHprocess,equipmentandcontroltechnology,inordertomeettheneedsofproductwithmorereasonableandeconomicprocess,exploitpotentialities,buildmoreeffective,lowercost,lowerenergyconsumption,protectingenvironmentRHfacilitieswillbethekeypointoffutureRHtechnologydevelopmentinChina.
简介:【摘要】目的:探讨新生儿 Rh 溶血病的临床特征及预后。方法:收集 2016 年 9 月至 2016 年 10 月于我院新生儿科住院的 Rh 溶血患儿,观察其临床特征 、 治疗方法及治疗效果。结果: 4 例患儿中有 3 例为第 2 胎第 2 产, 1 例为第 3 胎第 3 产。 3 例黄疸发生时间在生后 24 小时之内, 1 例在 48 小时之内。 4 例患儿均给予了光疗及输血治疗。其中 1 例进行换血治疗,应用白蛋白及丙球各 3 例。 4 例患儿脑干听及头颅 MRI 结果均未见异常,其中 1 例 b 超提示双侧室管膜下出血伴液化。结论:加强对 新生儿 Rh 溶血的认识 ,早期及轻症病例采用光疗加药物治疗即可取得良好效果 ;重症患儿,需采用换血治疗 。